Show simple item record

dc.contributor.authorDonghi, Monica*
dc.date.accessioned2021-02-11T22:19:52Z
dc.date.available2021-02-11T22:19:52Z
dc.date.issued2014*
dc.date.submitted2018-11-05 12:58:39*
dc.identifier29442*
dc.identifier.urihttps://directory.doabooks.org/handle/20.500.12854/55772
dc.description.abstractThis book investigates lifecycle management strategies used by pharmaceutical companies attempting to maximize the value of their product portfolio. Such strategies are sometimes referred to by generic drug companies as “evergreening”. The analysis focuses on two of these strategies, namely product improvements and product line extensions. In particular, an evaluation of the patents that follow the basic one and that accompany the development of a drug from research to market is attempted. Two “blockbuster” drugs, Taxotere and Xalatan, were randomly chosen to carry out such analysis. The patent portfolio of the originator companies is outlined and some important patents for each area of research (e.g. formulations, combinations, delivery devices) are shortly described. Patent filing trends for the two drugs, both in regards of the originator and in regards of other competing companies (amongst these also the generics) are schematically shown.*
dc.languageEnglish*
dc.relation.ispartofseriesMunich Intellectual Property Law Center – MIPLC*
dc.subjectK1-7720*
dc.subject.classificationbic Book Industry Communication::L Lawen_US
dc.subject.otherMarkenrecht*
dc.subject.otherUrheberrecht / Gewerblicher Rechtsschutz und Medienrecht*
dc.subject.otherGewerblicher Rechtsschutz*
dc.titlePatent Strategy in Pharmaceutical Industry: Are additional patents valuable?*
dc.typebook
oapen.identifier.doihttp://dx.doi.org/10.5771/9783845251288*
oapen.relation.isPublishedBy20c8b06d-3b2b-4af2-acda-fbcfdfea5744*
oapen.relation.isbn9783845251288*
oapen.pages84*
oapen.volume20*
oapen.edition1*


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record

https://creativecommons.org/licenses/by/4.0/
Except where otherwise noted, this item's license is described as https://creativecommons.org/licenses/by/4.0/